News
World Malaria Day 2024: Accelerating the development of innovative approaches to end malaria
On this World Malaria Day, under the theme ‘Accelerating the fight against malaria for a more equitable world’ we are reminded that more than 90%…
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Positive data from the phase II/III CALINA study, part of the EDCTP-funded PAMAfrica consortium, demonstrated that a novel formulation of Coartem® (artemether-lumefantrine) developed for babies…
World TB Day 2024: Funding innovative research to end TB
On this World TB Day 2024, EDCTP reinforces its commitment to investing in tuberculosis (TB) research and development, an important part of the jigsaw to…
An innovative and integrated intervention package delivered through the health system could protect infants from HIV
Paediatric HIV infections remain unacceptably high, with UNAIDS estimating 130,000 new cases in 2022, most of which occur during breastfeeding. The widespread implementation of universal…
International Women’s Day 2024: Investing in women to accelerate progress
This year on International Women’s Day, EDCTP joins the global health community in celebrating diversity and empowerment and underscores its commitment to investing in women…
World NTD Day 2024: investing to control and eliminate neglected tropical diseases
Global investment into research and development of new products for neglected tropical diseases (NTDs, also known as neglected infectious diseases) is limited and there is…
African women living with HIV have an effective option to prevent malaria during pregnancy
The combination of two antimalarial drugs (DHA-PPQ) reduces the risk of malaria infection and disease in pregnant women on HIV treatment, according to results from…
2023 End of the year message from Mr Abdoulie Barry, Acting Executive Director
Dear Colleagues, Partners and Friends, As we look forward to celebrating Christmas and New Year with our families and friends, it is important to highlight…
Early data shows that the H56:IC31 candidate vaccine did not provide protection against TB recurrence
The Statens Serum Institut (SSI) announced today that they will stop the development of the H56:IC31 tuberculosis (TB) candidate vaccine. The first analyses of data…
EMA recommends arpraziquantel for treatment of schistosomiasis in preschool-aged children
Today, the Pediatric Praziquantel Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive…
EMA gives positive opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of the use of Fexinidazole Winthrop…
PrEPVacc study reports that experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition
Today, the EDCTP-funded PrEPVacc HIV prevention study has announced that it stopped its experimental vaccine regimens as there is little or no chance of the…
Benin and Somalia join EDCTP Association
EDCTP is pleased to welcome Benin and Somalia on board as the newest member countries of the EDCTP Association, bringing the total number of African…
World AIDS Day 2023: 20 years of supporting innovative approaches to fight HIV/AIDS
Since its inception in 2003, EDCTP has had a strong focus on one of sub-Saharan Africa’s greatest health challenges: HIV/AIDS. On World AIDS Day 2023,…
Abdoulie Barry appointed as EDCTP Acting Executive Director
Mr. Abdoulie Barry has been appointed as Acting Executive Director of the EDCTP Association with effect from 16 November 2023. Abdoulie will combine the Executive…